Back to Screener

Healthcare

Sonova Holding AG(SONVY)

Live Price

Offline

$48.32

-1.59% today

Window Change

-8.57%

Window

May 29, 2026 β†’ Jun 18, 2026

Market Cap
$10.21B
Revenue Growth
+6.6%
EPS Growth
-9.8%
Dividend Yield
2.6%
Sparse coverage

Historical coverage is still filling in

This 1Y daily history view is currently sparse. Use it as directional context while we continue backfilling more history.

Coverage: 15 bars Β· May 29, 2026 β†’ Jun 18, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Sonova Holding AG (SONVY) is a Healthcare stock with a market cap of $10.21B and listed on OTC. The stock last traded around $48.32 and down 8.6% across the available one-year price window (May 29, 2026 β†’ Jun 18, 2026). Baseline metrics include revenue growth of +6.6%, EPS growth of -9.8%, a dividend yield of 2.6%. What stands out right now is revenue +6.6%, EPS -9.8%, free cash flow +5.0% with operating margin 18.2% and ROIC 12.6%. The dividend matters to the case here, with a current yield around 2.6%. Valuation is more restrained than many high-expectation growth names at P/E 19.6 and price/sales 2.7. Overall, the current profile looks closer to a income-oriented value setup than a generic broad-market placeholder. Stock Foundry combines SONVY price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Comparison

Normalized Performance vs SPY

Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.

1Y shared range

SONVY

β€”

Normalized return

SPY

β€”

S&P 500

Excess Return

β€”

Relative to SPY

SONVY Max Drawdown

-8.57%

Trailing 1Y

SPY Max Drawdown

β€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for SONVY and SPY.

Calendar-year return history is still loading or unavailable.

EPS Consensus

1.15

Range 1.15 β†’ 1.15

No analyst count

vs prior: +47.1%

Revenue Outlook

$2.1B

Range $2.1B β†’ $2.1B

No analyst count

vs prior: +14.2%

Consensus Spread

EPS spread0.0%
Revenue spread0.0%

Lower spread suggests tighter agreement across covering analysts.

Trend

EPS trend

Consensus average across visible periods

1.15
Latest visible period
Q3 2023Q1 2026
5 visible pointstrend: +47.1%

Trend

Revenue trend

Average analyst revenue estimate

$2.1B
Latest visible period
Q3 2023Q1 2026
5 visible pointstrend: +14.2%

Timeline

Analyst forecast ladder

Sorted by period end date. Includes both cached rows and live fallbacks from FMP.

Q1 2026
Ends Mar 30, 2026
quarter
Revenue
$2.1B
$2.1B to $2.1B
EPS
1.15
1.15 to 1.15
No analyst count
EPS: No analyst count
May 1, 07:07 PM UTC
stable/analyst-estimates
Q3 2025
Ends Sep 30, 2025
quarter
Revenue
$1.8B
$1.8B to $1.8B
EPS
0.78
0.78 to 0.78
No analyst count
EPS: No analyst count
May 1, 07:07 PM UTC
stable/analyst-estimates
Q3 2024
Ends Sep 30, 2024
quarter
Revenue
$1.8B
$1.8B to $1.8B
EPS
0.91
0.91 to 0.91
No analyst count
EPS: No analyst count
May 1, 07:07 PM UTC
stable/analyst-estimates
Q1 2024
Ends Mar 30, 2024
quarter
Revenue
$1.9B
$1.9B to $1.9B
EPS
1.05
1.05 to 1.05
No analyst count
EPS: No analyst count
May 1, 07:07 PM UTC
stable/analyst-estimates
Q3 2023
Ends Sep 29, 2023
quarter
Revenue
$1.8B
$1.8B to $1.8B
EPS
0.96
0.96 to 0.96
No analyst count
EPS: No analyst count
May 1, 07:07 PM UTC
stable/analyst-estimates

Next Step

Put consensus data in context

Forecasts are most valuable when they sit beside comparisons, earnings setup, and the rest of the business story.